H E Hohmeier
Overview
Explore the profile of H E Hohmeier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
607
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hohmeier H, Tran V, Chen G, Gasa R, Newgard C
Int J Obes Relat Metab Disord
. 2004 Jan;
27 Suppl 3:S12-6.
PMID: 14704737
Inflammation plays an important role in the destruction of pancreatic islet beta-cells that leads to type I diabetes. This involves infiltration of T-cells and macrophages into the islets and local...
2.
Chen G, Hohmeier H, Newgard C
J Biol Chem
. 2000 Oct;
276(1):766-72.
PMID: 11024034
Destruction of pancreatic islet beta-cells in type 1 diabetes appears to result from direct contact with infiltrating T-cells and macrophages and exposure to inflammatory cytokines such as interferon (IFN)-gamma, interleukin...
3.
Chen G, Hohmeier H, Gasa R, Tran V, Newgard C
Diabetes
. 2000 Jun;
49(4):562-70.
PMID: 10871193
Engineered insulinoma cell lines may represent an alternative to isolated islets for transplantation therapy of type 1 diabetes. Success of this approach may require development of cell lines that can...
4.
Hohmeier H, Mulder H, Chen G, Prentki M, Newgard C
Diabetes
. 2000 Jun;
49(3):424-30.
PMID: 10868964
The biochemical mechanisms involved in regulation of insulin secretion are not completely understood. The rat INS-1 cell line has been used to gain insight in this area because it secretes...
5.
Hohmeier H, Thigpen A, Tran V, Davis R, Newgard C
J Clin Invest
. 1998 Jun;
101(9):1811-20.
PMID: 9576743
The fact that insulin-producing islet beta-cells are susceptible to the cytotoxic effects of inflammatory cytokines represents a potential hinderance to the use of such cells for transplantation therapy of insulin-dependent...
6.
Newgard C, Clark S, BeltrandelRio H, Hohmeier H, Quaade C, Normington K
Diabetologia
. 1997 Jul;
40 Suppl 2:S42-7.
PMID: 9248700
The recently completed diabetes complications and control trial has highlighted the need for improvement of insulin delivery systems for treatment of insulin-dependent diabetes mellitus. Despite steady improvement in methods for...
7.
Hohmeier H, BeltrandelRio H, Clark S, Normington K, Newgard C
Diabetes
. 1997 Jun;
46(6):968-77.
PMID: 9166667
In the accompanying article, we describe the creation of novel cell lines derived from RIN 1046-38 rat insulinoma cells by stable transfection with combinations of genes encoding human insulin, GLUT2,...
8.
Schnedl W, Hohmeier H, Newgard C
Naturwissenschaften
. 1996 Jan;
83(1):1-5.
PMID: 8637602
Even with intensive insulin therapy it is impossible to reach physiological blood glucose levels in insulin-dependent diabetes mellitus. Because of the high costs and technical problems involved in islet cell...
9.
Konig U, Gotz H, Walter G, Babel D, Hohmeier H, Thinnes F, et al.
Biol Chem Hoppe Seyler
. 1991 Aug;
372(8):565-72.
PMID: 1659831
In recent papers we proved "Porin 31HL" to be located on the surface of human, EBV-transformed B lymphocytes. Here we present proof of "Porin 31HL" in the plasmalemma of normal...